nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM8—lung cancer	0.0201	0.0985	CbGpPWpGaD
Vigabatrin—ABAT—mammary gland—lung cancer	0.0175	0.194	CbGeAlD
Vigabatrin—GABBR1—bronchus—lung cancer	0.0123	0.136	CbGeAlD
Vigabatrin—GABBR1—cardiac atrium—lung cancer	0.0103	0.115	CbGeAlD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00938	0.0461	CbGpPWpGaD
Vigabatrin—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM8—lung cancer	0.00915	0.0449	CbGpPWpGaD
Vigabatrin—GABBR1—bone marrow—lung cancer	0.00873	0.0972	CbGeAlD
Vigabatrin—GABBR1—lung—lung cancer	0.00791	0.0881	CbGeAlD
Vigabatrin—SLC36A1—bone marrow—lung cancer	0.00686	0.0763	CbGeAlD
Vigabatrin—GABBR1—Activation of GABAB receptors—ADCY1—lung cancer	0.00661	0.0325	CbGpPWpGaD
Vigabatrin—SLC36A1—lung—lung cancer	0.00621	0.0692	CbGeAlD
Vigabatrin—ABAT—lung—lung cancer	0.00618	0.0687	CbGeAlD
Vigabatrin—GABBR1—lymph node—lung cancer	0.00541	0.0602	CbGeAlD
Vigabatrin—GABBR1—GABA receptor activation—ADCY1—lung cancer	0.00506	0.0249	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK3—lung cancer	0.00443	0.0218	CbGpPWpGaD
Vigabatrin—SLC36A1—lymph node—lung cancer	0.00425	0.0473	CbGeAlD
Vigabatrin—ABAT—lymph node—lung cancer	0.00422	0.047	CbGeAlD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00419	0.0206	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00392	0.0192	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—lung cancer	0.00361	0.0177	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—lung cancer	0.00336	0.0165	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—GRIK3—lung cancer	0.00333	0.0164	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00319	0.0157	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00318	0.0156	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—GRIK3—lung cancer	0.003	0.0147	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00297	0.0146	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—lung cancer	0.00274	0.0134	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CHRNB4—lung cancer	0.00272	0.0133	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG11—lung cancer	0.00259	0.0127	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GRIK3—lung cancer	0.00255	0.0125	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CHRNA5—lung cancer	0.00252	0.0124	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CHRNB4—lung cancer	0.00245	0.012	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.00242	0.0119	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY1—lung cancer	0.00233	0.0114	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—GNG11—lung cancer	0.00229	0.0112	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CHRNA5—lung cancer	0.00227	0.0112	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GRM8—lung cancer	0.00222	0.0109	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.00213	0.0105	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CHRNB4—lung cancer	0.00208	0.0102	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—ADCY1—lung cancer	0.00206	0.0101	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.00206	0.0101	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—GNG11—lung cancer	0.00195	0.00956	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CHRNA5—lung cancer	0.00193	0.0095	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—CHRNA3—lung cancer	0.00185	0.00911	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—GNG11—lung cancer	0.00175	0.00861	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—ADCY1—lung cancer	0.00175	0.0086	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—GNG11—lung cancer	0.00171	0.0084	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00161	0.00793	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GIPR—lung cancer	0.00158	0.00776	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—ADCY1—lung cancer	0.00158	0.00775	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—CHRNA3—lung cancer	0.00158	0.00775	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—ADCY1—lung cancer	0.00154	0.00755	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—GNG11—lung cancer	0.00149	0.00732	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—ANXA1—lung cancer	0.00134	0.0066	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GRM8—lung cancer	0.00134	0.0066	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—ADCY1—lung cancer	0.00134	0.00659	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—APP—lung cancer	0.00127	0.00626	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—OXTR—lung cancer	0.00111	0.00543	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GRP—lung cancer	0.00111	0.00543	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GNG11—lung cancer	0.00104	0.00509	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.000999	0.00491	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—lung cancer	0.000984	0.00483	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000967	0.00475	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GIPR—lung cancer	0.000893	0.00439	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000877	0.00431	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—BRAF—lung cancer	0.00087	0.00427	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTHLH—lung cancer	0.000866	0.00425	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—lung cancer	0.000825	0.00405	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—lung cancer	0.000822	0.00404	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—ANXA1—lung cancer	0.000814	0.004	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GIPR—lung cancer	0.000811	0.00398	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000788	0.00387	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000788	0.00387	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—APP—lung cancer	0.000772	0.00379	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRM8—lung cancer	0.000759	0.00373	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—BRAF—lung cancer	0.00074	0.00363	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—TF—lung cancer	0.000733	0.0036	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MDM2—lung cancer	0.000729	0.00358	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—RAF1—lung cancer	0.000727	0.00357	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRM8—lung cancer	0.000689	0.00339	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—BRAF—lung cancer	0.000667	0.00328	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—POMC—lung cancer	0.000659	0.00324	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AXL—lung cancer	0.000632	0.0031	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—OXTR—lung cancer	0.000625	0.00307	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GRP—lung cancer	0.000625	0.00307	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MDM2—lung cancer	0.00062	0.00305	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—RAF1—lung cancer	0.000618	0.00303	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—lung cancer	0.000606	0.00297	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—AVP—lung cancer	0.0006	0.00295	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GNG11—lung cancer	0.000585	0.00287	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GRP—lung cancer	0.000568	0.00279	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—OXTR—lung cancer	0.000568	0.00279	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—BRAF—lung cancer	0.000567	0.00278	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—MDM2—lung cancer	0.000559	0.00274	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—RAF1—lung cancer	0.000557	0.00273	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GNG11—lung cancer	0.000531	0.00261	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ADCY1—lung cancer	0.000526	0.00259	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—lung cancer	0.000509	0.0025	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AVP—lung cancer	0.000508	0.00249	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000492	0.00242	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—COL4A2—lung cancer	0.000492	0.00241	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PTHLH—lung cancer	0.000489	0.0024	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GIPR—lung cancer	0.000479	0.00235	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—ADCY1—lung cancer	0.000478	0.00235	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—MDM2—lung cancer	0.000475	0.00233	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—RAF1—lung cancer	0.000473	0.00233	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PPP2R1B—lung cancer	0.000466	0.00229	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—ANXA1—lung cancer	0.00046	0.00226	CbGpPWpGaD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—lung cancer	0.000453	0.00222	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SDC4—lung cancer	0.000447	0.0022	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTHLH—lung cancer	0.000444	0.00218	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DUSP3—lung cancer	0.000438	0.00215	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—APP—lung cancer	0.000436	0.00214	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RHEB—lung cancer	0.00043	0.00211	CbGpPWpGaD
Vigabatrin—Skin disorder—Paclitaxel—lung cancer	0.000419	0.000593	CcSEcCtD
Vigabatrin—Body temperature increased—Irinotecan—lung cancer	0.000418	0.000592	CcSEcCtD
Vigabatrin—Abdominal pain—Irinotecan—lung cancer	0.000418	0.000592	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000418	0.000592	CcSEcCtD
Vigabatrin—Decreased appetite—Cisplatin—lung cancer	0.000418	0.000591	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—ANXA1—lung cancer	0.000418	0.00205	CbGpPWpGaD
Vigabatrin—Pneumonia—Methotrexate—lung cancer	0.000416	0.000589	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—lung cancer	0.000415	0.000588	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000415	0.000587	CcSEcCtD
Vigabatrin—Anaemia—Docetaxel—lung cancer	0.000414	0.000586	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—lung cancer	0.000413	0.000585	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—lung cancer	0.000413	0.000585	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—lung cancer	0.000413	0.000585	CcSEcCtD
Vigabatrin—Depression—Methotrexate—lung cancer	0.000412	0.000583	CcSEcCtD
Vigabatrin—Pain—Cisplatin—lung cancer	0.000411	0.000582	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00041	0.00058	CcSEcCtD
Vigabatrin—Vomiting—Vinorelbine—lung cancer	0.000408	0.000577	CcSEcCtD
Vigabatrin—Body temperature increased—Gemcitabine—lung cancer	0.000408	0.000577	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRM8—lung cancer	0.000407	0.002	CbGpPWpGaD
Vigabatrin—Rash—Vinorelbine—lung cancer	0.000405	0.000573	CcSEcCtD
Vigabatrin—Dermatitis—Vinorelbine—lung cancer	0.000404	0.000572	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—lung cancer	0.000404	0.000572	CcSEcCtD
Vigabatrin—Headache—Vinorelbine—lung cancer	0.000402	0.000569	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—lung cancer	0.000402	0.000569	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—lung cancer	0.000402	0.000568	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HRAS—lung cancer	0.0004	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—POMC—lung cancer	0.000399	0.00196	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Cisplatin—lung cancer	0.000396	0.00056	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—APP—lung cancer	0.000396	0.00195	CbGpPWpGaD
Vigabatrin—Paraesthesia—Etoposide—lung cancer	0.000395	0.000559	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SKI—lung cancer	0.000394	0.00194	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000393	0.000557	CcSEcCtD
Vigabatrin—Somnolence—Etoposide—lung cancer	0.000391	0.000554	CcSEcCtD
Vigabatrin—Cough—Docetaxel—lung cancer	0.000391	0.000554	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—lung cancer	0.000391	0.000553	CcSEcCtD
Vigabatrin—Insomnia—Paclitaxel—lung cancer	0.00039	0.000553	CcSEcCtD
Vigabatrin—Hypersensitivity—Irinotecan—lung cancer	0.00039	0.000552	CcSEcCtD
Vigabatrin—Convulsion—Docetaxel—lung cancer	0.000388	0.00055	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—APOA1—lung cancer	0.000388	0.00191	CbGpPWpGaD
Vigabatrin—Paraesthesia—Paclitaxel—lung cancer	0.000388	0.000549	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—lung cancer	0.000386	0.000547	CcSEcCtD
Vigabatrin—Somnolence—Paclitaxel—lung cancer	0.000384	0.000543	CcSEcCtD
Vigabatrin—Decreased appetite—Etoposide—lung cancer	0.000383	0.000542	CcSEcCtD
Vigabatrin—Myalgia—Docetaxel—lung cancer	0.000382	0.00054	CcSEcCtD
Vigabatrin—Chest pain—Docetaxel—lung cancer	0.000382	0.00054	CcSEcCtD
Vigabatrin—Arthralgia—Docetaxel—lung cancer	0.000382	0.00054	CcSEcCtD
Vigabatrin—Nausea—Vinorelbine—lung cancer	0.000381	0.00054	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Etoposide—lung cancer	0.00038	0.000538	CcSEcCtD
Vigabatrin—Dyspepsia—Paclitaxel—lung cancer	0.00038	0.000538	CcSEcCtD
Vigabatrin—Body temperature increased—Cisplatin—lung cancer	0.00038	0.000538	CcSEcCtD
Vigabatrin—Asthenia—Irinotecan—lung cancer	0.00038	0.000537	CcSEcCtD
Vigabatrin—Fatigue—Etoposide—lung cancer	0.00038	0.000537	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000379	0.000536	CcSEcCtD
Vigabatrin—Constipation—Etoposide—lung cancer	0.000376	0.000533	CcSEcCtD
Vigabatrin—Pain—Etoposide—lung cancer	0.000376	0.000533	CcSEcCtD
Vigabatrin—Decreased appetite—Paclitaxel—lung cancer	0.000375	0.000531	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000373	0.000528	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000373	0.000527	CcSEcCtD
Vigabatrin—Fatigue—Paclitaxel—lung cancer	0.000372	0.000527	CcSEcCtD
Vigabatrin—Asthenia—Gemcitabine—lung cancer	0.00037	0.000524	CcSEcCtD
Vigabatrin—Pain—Paclitaxel—lung cancer	0.000369	0.000522	CcSEcCtD
Vigabatrin—Constipation—Paclitaxel—lung cancer	0.000369	0.000522	CcSEcCtD
Vigabatrin—Confusional state—Docetaxel—lung cancer	0.000369	0.000522	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—lung cancer	0.000366	0.000518	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—lung cancer	0.000365	0.000517	CcSEcCtD
Vigabatrin—Pruritus—Gemcitabine—lung cancer	0.000365	0.000516	CcSEcCtD
Vigabatrin—Infection—Docetaxel—lung cancer	0.000363	0.000514	CcSEcCtD
Vigabatrin—Feeling abnormal—Etoposide—lung cancer	0.000363	0.000513	CcSEcCtD
Vigabatrin—Diarrhoea—Irinotecan—lung cancer	0.000362	0.000513	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—lung cancer	0.00036	0.00051	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Etoposide—lung cancer	0.00036	0.00051	CcSEcCtD
Vigabatrin—Nervous system disorder—Docetaxel—lung cancer	0.000359	0.000508	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—lung cancer	0.000358	0.000507	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—lung cancer	0.000358	0.000507	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—lung cancer	0.000358	0.000507	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—lung cancer	0.000358	0.000506	CcSEcCtD
Vigabatrin—Feeling abnormal—Paclitaxel—lung cancer	0.000356	0.000503	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—lung cancer	0.000355	0.000503	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000355	0.000502	CcSEcCtD
Vigabatrin—Hypersensitivity—Cisplatin—lung cancer	0.000354	0.000501	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000353	0.0005	CcSEcCtD
Vigabatrin—Diarrhoea—Gemcitabine—lung cancer	0.000353	0.000499	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—lung cancer	0.000351	0.000497	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—lung cancer	0.000351	0.000497	CcSEcCtD
Vigabatrin—Dizziness—Irinotecan—lung cancer	0.00035	0.000495	CcSEcCtD
Vigabatrin—Urticaria—Etoposide—lung cancer	0.00035	0.000495	CcSEcCtD
Vigabatrin—Abdominal pain—Etoposide—lung cancer	0.000348	0.000493	CcSEcCtD
Vigabatrin—Body temperature increased—Etoposide—lung cancer	0.000348	0.000493	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—lung cancer	0.000348	0.000493	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—lung cancer	0.000348	0.000493	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—lung cancer	0.000347	0.000491	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—lung cancer	0.000346	0.00049	CcSEcCtD
Vigabatrin—Asthenia—Cisplatin—lung cancer	0.000345	0.000488	CcSEcCtD
Vigabatrin—Urticaria—Paclitaxel—lung cancer	0.000343	0.000485	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PXN—lung cancer	0.000343	0.00168	CbGpPWpGaD
Vigabatrin—Body temperature increased—Paclitaxel—lung cancer	0.000341	0.000483	CcSEcCtD
Vigabatrin—Abdominal pain—Paclitaxel—lung cancer	0.000341	0.000483	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HRAS—lung cancer	0.00034	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AVP—lung cancer	0.000339	0.00167	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Doxorubicin—lung cancer	0.000339	0.000479	CcSEcCtD
Vigabatrin—Vomiting—Irinotecan—lung cancer	0.000337	0.000476	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—lung cancer	0.000336	0.000475	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GRP—lung cancer	0.000335	0.00165	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKR1C1—lung cancer	0.000335	0.00165	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—OXTR—lung cancer	0.000335	0.00165	CbGpPWpGaD
Vigabatrin—Rash—Irinotecan—lung cancer	0.000334	0.000472	CcSEcCtD
Vigabatrin—Dermatitis—Irinotecan—lung cancer	0.000333	0.000472	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000333	0.000472	CcSEcCtD
Vigabatrin—Headache—Irinotecan—lung cancer	0.000332	0.000469	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—lung cancer	0.000331	0.000468	CcSEcCtD
Vigabatrin—Diarrhoea—Cisplatin—lung cancer	0.000329	0.000465	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000329	0.00161	CbGpPWpGaD
Vigabatrin—Paraesthesia—Docetaxel—lung cancer	0.000329	0.000465	CcSEcCtD
Vigabatrin—Vomiting—Gemcitabine—lung cancer	0.000328	0.000464	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—lung cancer	0.000325	0.00046	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—lung cancer	0.000325	0.00046	CcSEcCtD
Vigabatrin—Rash—Gemcitabine—lung cancer	0.000325	0.00046	CcSEcCtD
Vigabatrin—Dermatitis—Gemcitabine—lung cancer	0.000325	0.00046	CcSEcCtD
Vigabatrin—Hypersensitivity—Etoposide—lung cancer	0.000324	0.000459	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—lung cancer	0.000323	0.000457	CcSEcCtD
Vigabatrin—Headache—Gemcitabine—lung cancer	0.000323	0.000457	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—lung cancer	0.000322	0.000456	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—lung cancer	0.00032	0.000453	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—lung cancer	0.000318	0.00045	CcSEcCtD
Vigabatrin—Hypersensitivity—Paclitaxel—lung cancer	0.000318	0.00045	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—lung cancer	0.000317	0.000448	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000316	0.000447	CcSEcCtD
Vigabatrin—Asthenia—Etoposide—lung cancer	0.000316	0.000447	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—lung cancer	0.000316	0.000447	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—lung cancer	0.000315	0.000446	CcSEcCtD
Vigabatrin—Nausea—Irinotecan—lung cancer	0.000314	0.000445	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GNG11—lung cancer	0.000314	0.00154	CbGpPWpGaD
Vigabatrin—Pain—Docetaxel—lung cancer	0.000313	0.000443	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—lung cancer	0.000313	0.000443	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—lung cancer	0.000313	0.000442	CcSEcCtD
Vigabatrin—Pruritus—Etoposide—lung cancer	0.000311	0.000441	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—lung cancer	0.00031	0.000438	CcSEcCtD
Vigabatrin—Asthenia—Paclitaxel—lung cancer	0.00031	0.000438	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—lung cancer	0.000308	0.00152	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AVP—lung cancer	0.000308	0.00151	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—lung cancer	0.000308	0.00151	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—HRAS—lung cancer	0.000307	0.00151	CbGpPWpGaD
Vigabatrin—Nausea—Gemcitabine—lung cancer	0.000306	0.000433	CcSEcCtD
Vigabatrin—Vomiting—Cisplatin—lung cancer	0.000306	0.000432	CcSEcCtD
Vigabatrin—Pruritus—Paclitaxel—lung cancer	0.000305	0.000432	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—lung cancer	0.000305	0.000431	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—lung cancer	0.000304	0.00043	CcSEcCtD
Vigabatrin—Rash—Cisplatin—lung cancer	0.000303	0.000429	CcSEcCtD
Vigabatrin—Dermatitis—Cisplatin—lung cancer	0.000303	0.000428	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—lung cancer	0.000302	0.000427	CcSEcCtD
Vigabatrin—Diarrhoea—Etoposide—lung cancer	0.000301	0.000426	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—lung cancer	0.0003	0.000425	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—lung cancer	0.0003	0.000424	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—lung cancer	0.0003	0.000424	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—lung cancer	0.000299	0.000423	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—VEGFC—lung cancer	0.000299	0.00147	CbGpPWpGaD
Vigabatrin—Anaemia—Methotrexate—lung cancer	0.000299	0.000423	CcSEcCtD
Vigabatrin—Diarrhoea—Paclitaxel—lung cancer	0.000295	0.000418	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—lung cancer	0.000291	0.000412	CcSEcCtD
Vigabatrin—Dizziness—Etoposide—lung cancer	0.000291	0.000412	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—lung cancer	0.00029	0.000411	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—lung cancer	0.000289	0.000409	CcSEcCtD
Vigabatrin—Body temperature increased—Docetaxel—lung cancer	0.000289	0.000409	CcSEcCtD
Vigabatrin—Dizziness—Paclitaxel—lung cancer	0.000285	0.000404	CcSEcCtD
Vigabatrin—Nausea—Cisplatin—lung cancer	0.000285	0.000404	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ADCY1—lung cancer	0.000282	0.00139	CbGpPWpGaD
Vigabatrin—Cough—Methotrexate—lung cancer	0.000282	0.000399	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—lung cancer	0.000282	0.000399	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—lung cancer	0.00028	0.000396	CcSEcCtD
Vigabatrin—Vomiting—Etoposide—lung cancer	0.00028	0.000396	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—lung cancer	0.00028	0.000396	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—RAF1—lung cancer	0.000278	0.00137	CbGpPWpGaD
Vigabatrin—Rash—Etoposide—lung cancer	0.000278	0.000393	CcSEcCtD
Vigabatrin—Dermatitis—Etoposide—lung cancer	0.000277	0.000392	CcSEcCtD
Vigabatrin—Headache—Etoposide—lung cancer	0.000276	0.00039	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PPP2R1B—lung cancer	0.000275	0.00135	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SMARCA4—lung cancer	0.000275	0.00135	CbGpPWpGaD
Vigabatrin—Arthralgia—Methotrexate—lung cancer	0.000275	0.000389	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—lung cancer	0.000275	0.000389	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—lung cancer	0.000275	0.000389	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—lung cancer	0.000275	0.000389	CcSEcCtD
Vigabatrin—Vomiting—Paclitaxel—lung cancer	0.000274	0.000388	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000273	0.000387	CcSEcCtD
Vigabatrin—Rash—Paclitaxel—lung cancer	0.000272	0.000385	CcSEcCtD
Vigabatrin—Dermatitis—Paclitaxel—lung cancer	0.000272	0.000385	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—lung cancer	0.000272	0.000385	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—lung cancer	0.000272	0.000385	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—lung cancer	0.000271	0.000383	CcSEcCtD
Vigabatrin—Headache—Paclitaxel—lung cancer	0.00027	0.000383	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—lung cancer	0.00027	0.000382	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—lung cancer	0.000269	0.000381	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—lung cancer	0.000266	0.000376	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HSPB1—lung cancer	0.000265	0.0013	CbGpPWpGaD
Vigabatrin—Vision blurred—Doxorubicin—lung cancer	0.000264	0.000373	CcSEcCtD
Vigabatrin—Asthenia—Docetaxel—lung cancer	0.000263	0.000372	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PTHLH—lung cancer	0.000262	0.00129	CbGpPWpGaD
Vigabatrin—Infection—Methotrexate—lung cancer	0.000262	0.000371	CcSEcCtD
Vigabatrin—Nausea—Etoposide—lung cancer	0.000262	0.00037	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—HRAS—lung cancer	0.000261	0.00128	CbGpPWpGaD
Vigabatrin—Ill-defined disorder—Doxorubicin—lung cancer	0.00026	0.000367	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—lung cancer	0.000259	0.000366	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—lung cancer	0.000259	0.000366	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—lung cancer	0.000259	0.000366	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—lung cancer	0.000257	0.000364	CcSEcCtD
Vigabatrin—Nausea—Paclitaxel—lung cancer	0.000256	0.000363	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—lung cancer	0.000256	0.000363	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—lung cancer	0.000252	0.000357	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—lung cancer	0.000251	0.000356	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—lung cancer	0.00025	0.000354	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—ANXA1—lung cancer	0.000247	0.00121	CbGpPWpGaD
Vigabatrin—Cough—Doxorubicin—lung cancer	0.000244	0.000346	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—lung cancer	0.000242	0.000343	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—lung cancer	0.000242	0.000342	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00024	0.00034	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FLT1—lung cancer	0.000239	0.00117	CbGpPWpGaD
Vigabatrin—Insomnia—Methotrexate—lung cancer	0.000239	0.000338	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—lung cancer	0.000238	0.000337	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—lung cancer	0.000238	0.000337	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—lung cancer	0.000238	0.000337	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—lung cancer	0.000237	0.000336	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—lung cancer	0.000237	0.000335	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—lung cancer	0.000237	0.00116	CbGpPWpGaD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000237	0.000335	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—lung cancer	0.000235	0.000333	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—lung cancer	0.000234	0.000332	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH3—lung cancer	0.000234	0.00115	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APP—lung cancer	0.000234	0.00115	CbGpPWpGaD
Vigabatrin—Vomiting—Docetaxel—lung cancer	0.000233	0.000329	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—lung cancer	0.000232	0.000329	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FGF9—lung cancer	0.000232	0.00114	CbGpPWpGaD
Vigabatrin—Rash—Docetaxel—lung cancer	0.000231	0.000326	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—lung cancer	0.00023	0.000326	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—lung cancer	0.00023	0.000326	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—lung cancer	0.000229	0.000324	CcSEcCtD
Vigabatrin—Headache—Docetaxel—lung cancer	0.000229	0.000324	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—lung cancer	0.000228	0.000323	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000228	0.000322	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—lung cancer	0.000227	0.000322	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—lung cancer	0.000227	0.000321	CcSEcCtD
Vigabatrin—Pain—Methotrexate—lung cancer	0.000226	0.000319	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—POMC—lung cancer	0.000225	0.00111	CbGpPWpGaD
Vigabatrin—Nervous system disorder—Doxorubicin—lung cancer	0.000224	0.000317	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—lung cancer	0.000222	0.000314	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—JUNB—lung cancer	0.000222	0.00109	CbGpPWpGaD
Vigabatrin—Nausea—Docetaxel—lung cancer	0.000217	0.000308	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—lung cancer	0.000217	0.000308	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—lung cancer	0.000216	0.000305	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—lung cancer	0.000215	0.00106	CbGpPWpGaD
Vigabatrin—Urticaria—Methotrexate—lung cancer	0.000209	0.000296	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—lung cancer	0.000208	0.000295	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—lung cancer	0.000208	0.000295	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CD—lung cancer	0.000208	0.00102	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000208	0.000294	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—lung cancer	0.000207	0.000292	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—lung cancer	0.000205	0.00029	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—POMC—lung cancer	0.000205	0.00101	CbGpPWpGaD
Vigabatrin—Somnolence—Doxorubicin—lung cancer	0.000203	0.000287	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—STK11—lung cancer	0.000201	0.000988	CbGpPWpGaD
Vigabatrin—Dyspepsia—Doxorubicin—lung cancer	0.000201	0.000284	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—IL6R—lung cancer	0.0002	0.000981	CbGpPWpGaD
Vigabatrin—Decreased appetite—Doxorubicin—lung cancer	0.000198	0.000281	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000197	0.000279	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—lung cancer	0.000197	0.000279	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—lung cancer	0.000195	0.000276	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—lung cancer	0.000195	0.000276	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—lung cancer	0.000194	0.000275	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—FOXO3—lung cancer	0.000194	0.000954	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAP2K1—lung cancer	0.00019	0.000935	CbGpPWpGaD
Vigabatrin—Asthenia—Methotrexate—lung cancer	0.000189	0.000268	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CD—lung cancer	0.000189	0.000928	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Doxorubicin—lung cancer	0.000188	0.000266	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000187	0.000264	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—lung cancer	0.000187	0.000264	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—AVP—lung cancer	0.000182	0.000894	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CB—lung cancer	0.000181	0.000891	CbGpPWpGaD
Vigabatrin—Urticaria—Doxorubicin—lung cancer	0.000181	0.000257	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—lung cancer	0.000181	0.000255	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—lung cancer	0.000181	0.000255	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—lung cancer	0.00018	0.000255	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—IGF1R—lung cancer	0.000175	0.00086	CbGpPWpGaD
Vigabatrin—Dizziness—Methotrexate—lung cancer	0.000174	0.000247	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—lung cancer	0.000174	0.000856	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HES1—lung cancer	0.000172	0.000845	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RAF1—lung cancer	0.000169	0.000829	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Doxorubicin—lung cancer	0.000168	0.000238	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—lung cancer	0.000168	0.000237	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—IL2—lung cancer	0.000167	0.000818	CbGpPWpGaD
Vigabatrin—Rash—Methotrexate—lung cancer	0.000166	0.000235	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—lung cancer	0.000166	0.000235	CcSEcCtD
Vigabatrin—Headache—Methotrexate—lung cancer	0.000165	0.000234	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CB—lung cancer	0.000165	0.000809	CbGpPWpGaD
Vigabatrin—Asthenia—Doxorubicin—lung cancer	0.000164	0.000232	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—lung cancer	0.000162	0.000229	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—lung cancer	0.000158	0.000778	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB3—lung cancer	0.000157	0.000773	CbGpPWpGaD
Vigabatrin—Nausea—Methotrexate—lung cancer	0.000157	0.000222	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—lung cancer	0.000156	0.000221	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—IL2—lung cancer	0.000151	0.000743	CbGpPWpGaD
Vigabatrin—Dizziness—Doxorubicin—lung cancer	0.000151	0.000214	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TERT—lung cancer	0.000151	0.00074	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—FGFR1—lung cancer	0.000146	0.000719	CbGpPWpGaD
Vigabatrin—Vomiting—Doxorubicin—lung cancer	0.000145	0.000205	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—HIF1A—lung cancer	0.000144	0.000708	CbGpPWpGaD
Vigabatrin—Rash—Doxorubicin—lung cancer	0.000144	0.000204	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—lung cancer	0.000144	0.000204	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—lung cancer	0.000143	0.000202	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—APOA1—lung cancer	0.000139	0.000683	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KDR—lung cancer	0.000138	0.000677	CbGpPWpGaD
Vigabatrin—Nausea—Doxorubicin—lung cancer	0.000136	0.000192	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—KIT—lung cancer	0.000127	0.000624	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APC—lung cancer	0.000127	0.000624	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—lung cancer	0.000127	0.000624	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NRAS—lung cancer	0.000127	0.000624	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGF—lung cancer	0.000126	0.000617	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK3—lung cancer	0.000122	0.000597	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—POMC—lung cancer	0.000121	0.000594	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—BRAF—lung cancer	0.000119	0.000586	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6R—lung cancer	0.000118	0.000579	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CREBBP—lung cancer	0.000118	0.000578	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—lung cancer	0.000116	0.000568	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAP2K1—lung cancer	0.000112	0.000552	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CD—lung cancer	0.000112	0.000548	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—lung cancer	0.000111	0.000543	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KRAS—lung cancer	0.000109	0.000537	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—lung cancer	0.0001	0.000493	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MDM2—lung cancer	0.0001	0.000491	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—RAF1—lung cancer	9.97e-05	0.00049	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ERBB2—lung cancer	9.86e-05	0.000484	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CB—lung cancer	9.73e-05	0.000478	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MTOR—lung cancer	9.73e-05	0.000478	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—lung cancer	9.35e-05	0.000459	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRAS—lung cancer	9.29e-05	0.000456	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—lung cancer	9.03e-05	0.000444	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—lung cancer	8.95e-05	0.00044	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL2—lung cancer	8.94e-05	0.000439	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—lung cancer	8.89e-05	0.000437	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCND1—lung cancer	8.71e-05	0.000428	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JUN—lung cancer	8.69e-05	0.000427	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—lung cancer	8.46e-05	0.000415	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CDKN1A—lung cancer	8.43e-05	0.000414	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTEN—lung cancer	8.41e-05	0.000413	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—lung cancer	8.2e-05	0.000403	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EP300—lung cancer	8.02e-05	0.000394	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SRC—lung cancer	7.8e-05	0.000383	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—lung cancer	7.6e-05	0.000373	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—lung cancer	7.52e-05	0.000369	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRAS—lung cancer	7.5e-05	0.000369	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK3—lung cancer	7.19e-05	0.000353	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—lung cancer	6.99e-05	0.000343	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—lung cancer	6.84e-05	0.000336	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KRAS—lung cancer	6.46e-05	0.000317	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—lung cancer	5.93e-05	0.000291	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—lung cancer	5.74e-05	0.000282	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRAS—lung cancer	5.49e-05	0.00027	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—lung cancer	5.25e-05	0.000258	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—lung cancer	4.85e-05	0.000238	CbGpPWpGaD
